Grantee & Partner News | National Center for Advancing Translational Sciences

Skip to main content

U.S. Department of Health & Human Services

National Institutes of Health

In the Spotlight

medical data is filtered through AI. An arrow labeled Potential Long COVID point to a woman

Using AI to Advance Understanding of Long COVID Syndrome

NIH Director's Blog ∙ 06/07/2022 ∙ CTSA Program

The COVID-19 pandemic continues to present considerable public health challenges in the United States and around the globe. One of the most puzzling is why many people who get over an initial and often relatively mild COVID illness later develop new and potentially debilitating symptoms. These symptoms run the gamut including fatigue, shortness of breath, brain fog, anxiety, and gastrointestinal trouble.

The National COVID Cohort Collaborative (N3C), a national, publicly available data resource sponsored by NCATS, is part of NIH’s Researching COVID to Enhance Recovery (RECOVER) initiative, which aims to improve understanding of Long COVID.

June 2022

Modeling a Devastating Childhood Disease on a Chip
Wyss Institute ∙ 06/23/2022 ∙ Tissue Chip
Five-Year, Multi-Site Trial to Assess Lymphedema Prevention Concludes
Vanderbilt University Medical Center ∙ 06/20/2022 ∙ CTSA Program
Walking Gives the Brain a ‘Step-Up’ in Function for Some
University of Rochester Medical Center ∙ 06/17/2022 ∙ CTSA Program
Computer Tool Can Track Stroke Rehabilitation to Boost Recovery
NYU Langone Health ∙ 06/16/2022 ∙ CTSA Program
Treating Parkinson’s Disease with Pinpoint Precision
I Am Intramural Blog ∙ 06/15/2022 ∙ Division of Preclinical Innovation
Pediatric Liver Disease Increases Risk of Developing Type 2 Diabetes
University of California, San Diego ∙ 06/13/2022 ∙ CTSA Program
Study Finds No Benefit to Taking Ivermectin for COVID-19 Symptoms
Duke University Health System ∙ 06/13/2022 ∙ CTSA Program
Study Reveals Genetic Differences Among Fetal Monocytes
Northwestern University, Feinberg School of Medicine ∙ 06/09/2022 ∙ CTSA Program
Santhera and ReveraGen to Present New Data with Vamorolone at 2022 Parent Project Muscular Dystrophy Conference
Santhera Pharmaceuticals ∙ 06/09/2022 ∙ NCATS
Using AI to Advance Understanding of Long COVID Syndrome
NIH Director's Blog ∙ 06/07/2022 ∙ CTSA Program
UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East
University of Arkansas for Medical Sciences ∙ 06/07/2022 ∙ CTSA Program
Causes of Liver Cancer are Changing Around the World: Some Up, Some Down
University of California, San Diego ∙ 06/06/2022 ∙ CTSA Program
NIH-Supported Study Links Poor Sleep to Increased Risk of COPD Flare-ups
NHLBI ∙ 06/06/2022 ∙ CTSA Program
‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 06/05/2022 ∙ NCATS
xCures joins C-Path’s Cure Drug Repurposing Collaboratory to Deliver AI-enabled Data Abstraction of Health Records
xCures ∙ 06/02/2022 ∙ NCATS
Exercise Amplifies Immune Attack on Pancreatic Cancer
NYU Langone Health ∙ 06/02/2022 ∙ CTSA Program
RENCI and RTI International Expand Strategic Partnership
RENCI (Renaissance Computing Institute) ∙ 06/02/2022 ∙ Biomedical Data Translator
Consortium Spotlight: Advancing Discoveries in Mitochondrial Diseases
Rare Diseases Clinical Research Network ∙ 06/01/2022 ∙ RDCRN
Exploiting a Vulnerability in an Aggressive Leukemia Affecting Babies
Boston Children's Hospital ∙ 06/01/2022 ∙ CTSA Program
Gene Therapy for Rare Eye Disease Safe but Lacks Efficacy in Early Trial
NIH ∙ 06/01/2022 ∙ GARD

May 2022

UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/31/2022 ∙ CTSA Program
UK Study: Asymptomatic COVID-19 Could Still Cause Pregnancy Risks
University of Kentucky ∙ 05/30/2022 ∙ CTSA Program
Georgia State Researchers Awarded More Than $6 Million to Fight Emerging Diseases with Midwest Antiviral Drug Discovery Center
Georgia State University ∙ 05/26/2022 ∙ NCATS
Patient Spotlight: Estopinan Family Advocates for TK2-Related Mitochondrial DNA Depletion Syndrome
Rare Diseases Clinical Research Network ∙ 05/26/2022 ∙ RDCRN
Inappropriate Antibiotics for Nonhospitalized Kids Cost US At Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
Inappropriate Antibiotics for Nonhospitalized Kids Cost US at Least $74 Million
Washington University in St. Louis ∙ 05/26/2022 ∙ CTSA Program
U of M Receives NIAID Grant to Develop Drug Treatments for Future Viral Pandemics
University of Minnesota Medical School ∙ 05/23/2022 ∙ Division of Preclinical Innovation
Use Cases Show Translator's Potential to Expedite Clinical Research
North Carolina Translational and Clinical Sciences Institute ∙ 05/23/2022 ∙ Biomedical Data Translator
First Treatment for Eosinophilic Esophagitis Wins FDA Approval
Cincinnati Children's Hospital Medical Center ∙ 05/20/2022 ∙ RDCRN
Deadly Disparities in the Time of COVID-19: Behind the Report
University of Illinois Chicago, Center for Clinical and Translational Science ∙ 05/19/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Zarazuela Zolkipli-Cunningham Designs Novel Outcome Measures for Mitochondrial Disease
Rare Diseases Clinical Research Network ∙ 05/19/2022 ∙ RDCRN
COVID Booster Needed for Broad Protection against Omicron Variants
The Ohio State University ∙ 05/18/2022 ∙ CTSA Program
A Computational Approach to Curbing Chemotherapy’s Side Effects
I Am Intramural Blog ∙ 05/17/2022 ∙ Division of Preclinical Innovation
Scientists Use Machine Learning Models to Help Identify Long COVID Patients
University of North Carolina School of Medicine ∙ 05/16/2022 ∙ CTSA Program
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University, College of Engineering & Computing ∙ 05/16/2022 ∙ Division of Preclinical Innovation
Innovation through Academic-Industry Partnerships in Clinical Trials
The University of Chicago, Polsky Center for Entrepreneurship and Innovation ∙ 05/16/2022 ∙ NCATS
Healing Chronic Pain? An Update on the NIH’s $2 Billion HEAL Project to End Chronic Pain
Health Rising ∙ 05/15/2022 ∙ HEAL
In New Age of Telemedicine, CHOP Researchers Identify Child Neurology Patients Who Still Require In-Person Visits
The Children’s Hospital of Philadelphia ∙ 05/13/2022 ∙ CTSA Program
Markey Study Finds 'Super Gene' Shows Promise for Preventing Obesity
University of Kentucky ∙ 05/13/2022 ∙ CTSA Program
Clinical and Translational Research Receives $61 Million Grant Support
Washington University in St. Louis ∙ 05/12/2022 ∙ CTSA Program
Five Questions with Qi Sun
Harvard Catalyst ∙ 05/12/2022 ∙ CTSA Program
Sound Pharmaceuticals Receives NIH Grant for Covid-19 Therapy Development
Pharmaceutical Technology ∙ 05/12/2022 ∙ NCATS
Smoking-Cessation Program That Targets Cancer Patients Effective
Washington University School of Medicine in St. Louis ∙ 05/11/2022 ∙ CTSA Program
U.S. Patent Awarded to FIU Researchers Could Be Key to Treating and Preventing Cardiovascular Disease
Florida International University ∙ 05/11/2022 ∙ Division of Preclinical Innovation
Netflix’s ‘Bandersnatch’ Inspires UAMS Researchers’ Opioid Misuse Game for Adolescents
University of Arkansas for Medical Sciences ∙ 05/11/2022 ∙ CTSA Program
Sound Pharmaceuticals’ NIH Grant for a Novel Oral COVID-19 Treatment Increases to $4.2M
Sound Pharmaceuticals, Inc. ∙ 05/11/2022 ∙ NCATS
FSU Continues to Advance Translational Research with New Grant from the National Library of Medicine
Florida State University ∙ 05/11/2022 ∙ CTSA Program
Smell and Taste Loss Less Likely with Newer COVID-19 Variants
Virginia Commonwealth University ∙ 05/11/2022 ∙ CTSA Program
Medication That Lowers Risk of Overdose Underused
Washington University School of Medicine in St. Louis ∙ 05/10/2022 ∙ CTSA Program
DoD Vision, Focused Translational Team Science Award
Global Database Ltd. ∙ 05/10/2022 ∙ Division of Preclinical Innovation
The Essentials of Single IRB Review
Harv ∙ 05/06/2022 ∙ CTSA Program
SC CTSI and Georgia CTSA Partner Creating Innovative Career Training and Advancement Platform
Southern California Clinical and Translational Science Institute ∙ 05/05/2022 ∙ CTSA Program
NCATS-Funded WUSTL Research Uses Synthetic Data to Accurately Model COVID-19 Populations
Federal Laboratory Consortium for Technology Transfer ∙ 05/05/2022 ∙ CTSA Program
Antibiotics Less Effective in Kids with More Appendicitis Pain
FitnessBblogger ∙ 05/05/2022 ∙ CTSA Program
Use Cases Show Translator’s Potential to Expedite Clinical Research
RENCI (Renaissance Computing Institute) ∙ 05/04/2022 ∙ Biomedical Data Translator
BioSystics, Inc. Is Introducing the BioSystics Analytics Platform™️ (BioSystics-AP™️) at the Microphysiology Systems World Summit in New Orleans, May 30–June 3, 2022
BioSystics, Inc. ∙ 05/04/2022 ∙ Tissue Chip
Vitamins, Minerals Improve Symptoms for Children with ADHD
Oregon Health & Science University ∙ 05/04/2022 ∙ CTSA Program
International Study Finds Nearly 13% of COVID-19 Hospitalized Patients Had Serious Neurologic Symptoms
Boston University School of Medicine ∙ 05/04/2022 ∙ CTSA Program
Blood Marker Shows Potential for Tracking Frontotemporal Dementia
NIH Research Matters ∙ 05/03/2022 ∙ Rare Diseases
NJ ACTS Pilot Program Letter of Intent Deadline May 6, 2022
Rutgers Institute for Translational Medicine and Science ∙ 05/02/2022 ∙ CTSA Program
Youths of Color Use Photographs to Highlight Health-care Inequities throughout COVID-19 Pandemic
Boston University School of Medicine ∙ 05/02/2022 ∙ CTSA Program

April 2022

Ridner Concludes Five-Year Multisite Trial to Assess Lymphedema Prevention
Vanderbilt University ∙ 04/28/2022 ∙ CTSA Program
Science Update: Youth Suicides Increased in First Year of the Pandemic, NIH-Funded Study Suggests
NICHD ∙ 04/27/2022 ∙ CTSA Program
Synthetic Data Mimics Real Patient Data, Accurately Models COVID-19 Pandemic
Washington University School of Medicine in St. Louis ∙ 04/27/2022 ∙ CTSA Program
Three CTSA Program Hubs Announced as Recipients of the 2022 AAMC Innovations Award
University of Rochester Center for Leading Innovation and Collaboration (CLIC) ∙ 04/27/2022 ∙ CTSA Program
Viruses in the Gut Influence Inflammatory Bowel Disease
NIH Research Matters ∙ 04/26/2022 ∙ CTSA Program
Presumptive Service Connection for Rare Respiratory Cancers Due to Exposure to Fine Particulate Matter
Federal Register ∙ 04/26/2022 ∙ Rare Diseases
Making Movement Fun May Help New Moms with Heart Risks
NHLBI ∙ 04/26/2022 ∙ CTSA Program
A More Precise Way to Knock Out Skin Rashes
NIH Director's Blog ∙ 04/26/2022 ∙ NCATS
If You Build It, Will They Come? Linking ICTS Researcher Engagement and Scientific Productivity
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
2022 ICTS Symposium Posters
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 04/25/2022 ∙ CTSA Program
Federal Research Funding Has Positive ‘Ripple Effects’
The Ohio State University ∙ 04/22/2022 ∙ NCATS
Early Stage Investigator Spotlight: Siddharth Srivastava Investigates Genetic Causes of Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/21/2022 ∙ RDCRN
Introducing SARS-CoV-2 Variants Overview, NLM’s Latest Tool in the Fight against COVID-19
National Center for Biotechnology Information ∙ 04/20/2022 ∙ Division of Preclinical Innovation
Hesperos Shows Potential for In Vitro Approach to Replace Conventional Animal Efficacy Studies for Rare Neuromuscular Disorders
Hesperos, Inc. ∙ 04/19/2022 ∙ SBIR/STIR, Tissue Chip
Smartwatches and Fitness Bands Reveal Individual Physiological Responses to COVID-19 Vaccine
The Scripps Research Institute ∙ 04/19/2022 ∙ CTSA Program
NCATS Aims to Transform Rare Disease Research
NIH Record ∙ 04/15/2022 ∙ Rare Diseases
Isotonizene Can Be Fun for Anyone
mybjjblog.com ∙ 04/15/2022 ∙ NCATS
Consortium Spotlight: Advancing Discoveries in Neurodevelopmental Disorders
Rare Diseases Clinical Research Network ∙ 04/14/2022 ∙ RDCRN
New COVID-19 Nasal Spray Outperforms Current Antibody Treatments in Mice
Northwestern University ∙ 04/13/2022 ∙ Tissue Chip
Three Doses of COVID-19 Vaccine Important for Patients Who Undergo Solid Organ Transplants
Washington University in St. Louis ∙ 04/13/2022 ∙ CTSA Program
Science Update: Scientists Develop Noninvasive Method to Predict Congenital CMV Infection
NICHD ∙ 04/13/2022 ∙ CTSA Program
CHOP Division of Urology Research Highlights 2021-2022
Children’s Hospital of Philadelphia ∙ 04/12/2022 ∙ CTSA Program
Five Questions With Lotfi Merabet
Harvard Catalyst ∙ 04/12/2022 ∙ CTSA Program
Research in Human Kidney Organoids Reveals Target to Prevent Irreversible Kidney Damage
MassaMassachusetts General Hospital ∙ 04/11/2022 ∙ CTSA Program
BARDA Announces Winners of EHR-Focused Pediatric COVID-19 Data Challenge
Federal Laboratory Consortium for Technology Transfer ∙ 04/07/2022 ∙ NCATS
Researchers Identify Oral Bacteria Strains Linked to High Blood Pressure
NHLBI ∙ 04/06/2022 ∙ CTSA Program
A New ‘Moneyball’: Model Switches Up How Baseball Players Are Valued
ScienceBlog.com ∙ 04/06/2022 ∙ CTSA Program
Major Grant Renewal to Provide Five More Years of Support for VICTR
Vanderbilt University Medical Center ∙ 04/06/2022 ∙ CTSA Program
Unlocking Insights from Real-World Data to Help Pediatric COVID-19 Patients
MedicalCountermeasures.gov ∙ 04/06/2022 ∙ CTSA Program
FSU Team Wins Global Competition to Develop Next-Gen Tools, Improve Public Health Solutions
Florida State University ∙ 04/05/2022 ∙ NCATS
New Metric More Accurately Evaluates Physician Performance
Northwestern University ∙ 04/05/2022 ∙ CTSA Program
New Study Shows Low D3Cr Muscle Mass/Weight Significantly Increases Risk of Hip and Potentially Other Fractures in Older Men
Sutter Health ∙ 04/04/2022 ∙ CTSA Program
Convalescent Plasma Could Lower Hospitalization Risk for Newly Infected COVID-19 Patients
The University of Utah ∙ 04/04/2022 ∙ NCATS
ILLInet RECOVER Will Help to Solve the Medical Mystery of “Long COVID”
UIC Center for Clinical and Translational Science ∙ 04/02/2022 ∙ CTSA Program

March 2022

Virpax Pharmaceuticals Reports 2021 Year-End Results
Virpax® Pharmaceuticals, Inc. ∙ 03/31/2022 ∙ NCATS
Santhera and ReveraGen Start Rolling NDA Submission to the FDA for Vamorolone for the Treatment of Duchenne Muscular Dystrophy
Yahoo! Finance ∙ 03/29/2022 ∙ NCATS
Patient Spotlight: Billy Anton Balances Management and Lifestyle with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/29/2022 ∙ RDCRN
Rural Hospital Administrators’ Beliefs on Offering Obstetric Care
University of Minnesota ∙ 03/25/2022 ∙ CTSA Program
'Father of Environmental Justice' and Local High School Students Headline CCTS Conference
University of Kentucky ∙ 03/25/2022 ∙ CTSA Program
In Animal Study, Implant Churns Out CAR-T Cells to Combat Cancer
North Carolina State University ∙ 03/24/2022 ∙ CTSA Program
Biomedical Data Translator Platform Moves to the Next Phase
RENCI (Renaissance Computing Institute) ∙ 03/24/2022 ∙ Biomedical Data Translator
Mayo Clinic Researchers Develop New Antibody Test to Diagnose MS
Mayo Clinic ∙ 03/24/2022 ∙ CTSA Program
COVID-19 Infection Linked to Higher Risk of Neuropathy
Washington University School of Medicine in St. Louis ∙ 03/24/2022 ∙ CTSA Program
Targeting TGF-β for Treatment of Osteogenesis Imperfecta
Baylor College of Medicine ∙ 03/22/2022 ∙ RDCRN
Early Stage Investigator Spotlight: BreAnna Kinghorn Improves Outcomes for Children with Primary Ciliary Dyskinesia
Rare Diseases Clinical Research Network ∙ 03/22/2022 ∙ RDCRN
COVID-19 Makes Living with a Rare Disease Even Harder
National Library of Medicine ∙ 03/22/2022 ∙ RDCRN
Tufts CTSI Publishes First-of-Its-Kind Resource on Real-World Research Conducted with Broadly Engaged, Diverse, and Inclusive Teams
Tufts Clinical and Translational Science Institute ∙ 03/21/2022 ∙ CTSA Program
"Fine-Tuning" Innovations to Predict Manic Episodes in Bipolar Disorder
UIC Center for Clinical and Translational Science ∙ 03/21/2022 ∙ CTSA Program
Help Us Enhance Diversity in Alzheimer’s and Related Dementias Clinical Trials
National Institute on Aging ∙ 03/21/2022 ∙ CTSA Program
Relapsing Polychondritis Patients, Advocates, and Researchers Emphasize Awareness, Partnership, and Collaboration with Exhibits on Rare Disease Day 2022 at the National Institutes of Health
Relapsing Polychondritis Foundation ∙ 03/17/2022 ∙ Rare Diseases
Blood Test May Indicate Higher Risk Pregnancies in Patients with COVID-19
Northwestern University ∙ 03/17/2022 ∙ CTSA Program
Coaching Transforms Researchers and Institutions
University of Minnesota, Clinical & Translational Science Institute ∙ 03/16/2022 ∙ CTSA Program
Finding the ‘Tipping Point’ to Permanent Kidney Damage
NIH Director's Blog ∙ 03/15/2022 ∙ Tissue Chip
Santhera and ReveraGen to Present Efficacy and Safety Data with Vamorolone at 2022 Muscular Dystrophy Association Conference
Santhera Pharmaceuticals and ReveraGen BioPharma ∙ 03/15/2022 ∙ NCATS
Weight Loss Doesn’t Help Pregnancy Chances, UVA’s Collaborative Health Study Finds
University of Virginia ∙ 03/14/2022 ∙ CTSA Program
Seminar Explores Similarities between Long COVID and Traumatic Brain Injury
University at Buffalo, Clinical and Translational Science Institute ∙ 03/14/2022 ∙ CTSA Program
Hospitalizations for High Blood Pressure May Be on the Rise
NHLBI ∙ 03/14/2022 ∙ CTSA Program
Close the Blinds during Sleep to Protect Your Health
Northwestern University ∙ 03/14/2022 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Mucociliary Clearance Diseases
Rare Diseases Clinical Research Network ∙ 03/11/2022 ∙ RDCRN
Prenatal Mindfulness Program Improves Stress Response in Infants
University of California, San Francisco ∙ 03/10/2022 ∙ CTSA Program
Universal Masking in Schools is Shown to Reduce Spread of COVID-19
Duke Clinical Research Institute ∙ 03/09/2022 ∙ CTSA Program
O-pH, a New UW Dental Tool Prototype, Can Spot the Acidic Conditions That Lead to Cavities
University of Washington ∙ 03/08/2022 ∙ NCATS
COVID-19 Immune Response Improves for Months after Vaccination
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
Getting Sufficient Sleep Reduces Calorie Intake
NIH Research Matters ∙ 03/08/2022 ∙ CTSA Program
Continuing Face Mask Use Could Save U.S. Billions of Dollars
CUNY Graduate School of Public Health and Health Policy ∙ 03/08/2022 ∙ CTSA Program
Study Shows Structural Racism Can Result in Poorer Leukemia Outcomes
University of Illinois at Chicago ∙ 03/07/2022 ∙ CTSA Program
‘Immune Distraction’ from Previous Colds Leads to Worse COVID Infections
University of Rochester Medical Center ∙ 03/04/2022 ∙ CTSA Program
Pregnant Women Have Lingering Depression Despite Antidepressant Treatment
Northwestern University ∙ 03/04/2022 ∙ CTSA Program
Early Stage Investigator Spotlight: Girish Hiremath Explores the Epidemiology of Eosinophilic Gastrointestinal Diseases
Rare Diseases Clinical Research Network ∙ 03/04/2022 ∙ Rare Diseases, RDCRN
Meet the Makers: NIH Biomedical Engineers Shape Tomorrow’s Technology
The NIH Catalyst ∙ 03/03/2022 ∙ Division of Preclinical Innovation
U of M Researchers Find Cohorting Patient Care Model during Pandemic Improved Patient Outcomes
University of Minnesota Medical School ∙ 03/03/2022 ∙ CTSA Program
Navigating the Rare Disease Odyssey
The Jackson Laboratory ∙ 03/02/2022 ∙ GARD, Rare Diseases
4 Agencies Select 8 Research Projects to Extend Longevity of 3D Tissue Chips to 6 Months
National Aeronautics and Space Administration ∙ 03/01/2022 ∙ Tissue Chip

February 2022

Exercise Reduces Clotting Risk in Patients with Nonalcoholic Fatty Liver Disease
Penn State ∙ 02/28/2022 ∙ CTSA Program
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs
Yahoo! Finance ∙ 02/28/2022 ∙ Rare Diseases
Rare Disease Day 2022: The Evolving Impact of Genomics and Precision Health
Centers for Disease Control and Prevention ∙ 02/28/2022 ∙ GARD, New Therapeutic Uses, Rare Diseases
Community Support Can Make You Healthier — And Can Help You Lose Weight, Too
Mayo Clinic ∙ 02/24/2022 ∙ CTSA Program
Trial Innovation Network Provides Resources for Investigators
University at Buffalo ∙ 02/24/2022 ∙ CTSA Program
Predicting the Chaos in Tourette Syndrome Tics
Washington University in St. Louis ∙ 02/23/2022 ∙ CTSA Program
Rare ≠ Uncommon: Patient Advocates Aim to Increase Visibility of Orphan Diseases
BioCentury, Inc. ∙ 02/22/2022 ∙ Rare Diseases
UVA Health Joins National Trial Testing Medications for Mild to Moderate COVID-19
University of Virginia ∙ 02/21/2022 ∙ CTSA Program
SARS-CoV-2 Infection Increases Risk of Maternal Mortality and Obstetric Complications
Northwestern University, Feinberg School of Medicine ∙ 02/21/2022 ∙ CTSA Program
Steps to Improve Data Gathering on Rare Diseases
Global Genes ∙ 02/18/2022 ∙ Rare Diseases
Science Federation Highlights Penn State Proposal to Combat Diseases of Despair
Penn State ∙ 02/17/2022 ∙ CTSA Program
Children with Insomnia Likely to Continue to Suffer as Adults, Long-Term Study Finds
Penn State ∙ 02/17/2022 ∙ NCATS
Study Will Test Higher Dose of Ivermectin to Treat Mild-to-Moderate COVID-19
Duke Clinical Research Institute ∙ 02/17/2022 ∙ CTSA Program
Household Food Insecurity during Adolescence is a Risk Factor for Future Disordered Eating and High Weight Status in Young Adulthood
University of Minnesota ∙ 02/17/2022 ∙ CTSA Program
Virtual Coaching to Increase Physical Activity in Frail Older Adults
University of Illinois Chicago, Center for Clinical and Translational Science ∙ 02/17/2022 ∙ CTSA Program
Quantifying the Economic Burden of Rare Diseases on Families and Health Care Systems
WCG Institute ∙ 02/17/2022 ∙ Rare Diseases
How Broad Scientists Are Bridging the Gap between Biological Insights and New Therapies
Broad Institute ∙ 02/16/2022 ∙ NCATS
Antibodies Improve in Quality for Months after COVID-19 Vaccination
Washington University in St. Louis ∙ 02/15/2022 ∙ CTSA Program
Sparking Change: UK Undergrad Program for Health Equity Research Expands to KSU
University of Kentucky Center for Clinical and Translational Science ∙ 02/15/2022 ∙ CTSA Program
Targeting TGF-β for Treatment of Osteogenesis Imperfecta
Baylor College of Medicine ∙ 02/15/2022 ∙ RDCRN
Hillstream BioPharma Provides Business Review with Key Pipeline Updates
Hillstream Biopharma, Inc. ∙ 02/14/2022 ∙ NCATS
IRP Pushes Forward in Fight against Pandemic Virus
I Am Intramural Blog ∙ 02/14/2022 ∙ Division of Preclinical Innovation
Renewal of License Subscription to Access Flare LigandPro, Forge GUI, Spark GUI and Engine Broker 5-User Group Software
Global Database, Ltd. ∙ 02/11/2022 ∙ Division of Preclinical Innovation
Improving Models to Predict Cardiovascular Disease in Individuals with Kidney Dysfunction
American Society of Nephrology ∙ 02/10/2022 ∙ NCATS
Virpax Reports Favorable Preclinical Safety Data for Envelta™ for the Treatment of Acute and Chronic Pain
Virpax® Pharmaceuticals, Inc. ∙ 02/10/2022 ∙ NCATS
Narratives of Discovery – Article 5: George Hripcsak
Columbia University, Irving Institute for Clinical and Translational Research ∙ 02/10/2022 ∙ CTSA Program
Improving Models to Predict Cardiovascular Disease in Individuals with Kidney Dysfunction
American Society of Nephrology ∙ 02/10/2022 ∙ NCATS
Results of First Clinical Trial of Niclosamide Antiviral in Patients with Covid-19 Show Further Research Needed
Tufts Clinical and Translational Science Institute ∙ 02/09/2022 ∙ CTSA Program
K Scholar’s Research on Mental Health and Pediatric Diabetes Highlighted by Cleveland Clinic
University of Kentucky Center for Clinical and Translational Science ∙ 02/08/2022 ∙ CTSA Program
Innovation to Respond to COVID-19
U.S. Food and Drug Administration ∙ 02/08/2022 ∙ Division of Preclinical Innovation
COVID-19 Linked to Serious Health Complications during Pregnancy
University of Utah Health ∙ 02/07/2022 ∙ CTSA Program
New Antiviral Drug Combination Is Highly Effective against SARS-CoV-2, Penn Study Finds
Penn Medicine ∙ 02/07/2022 ∙ Division of Preclinical Innovation
Nationwide Study of 'Long COVID' to Launch at University of Colorado Anschutz Medical Campus
Colorado Clinical and Translational Sciences Institute ∙ 02/07/2022 ∙ CTSA Program
A Guide to Next Steps after Not Receiving a Diagnosis
Global Genes ∙ 02/04/2022 ∙ GARD
Survey Finds Support for Cancer Warnings on Alcohol
WorldHealth.net ∙ 02/01/2022 ∙ CTSA Program
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2022 Annual Meeting Highlighting HSB-510, a Novel Quatramer-based, First-in-Class Dual Inhibitor of HDAC6 and PI3K-delta Downregulating c-myc Expression
Hillstream Biopharma, Inc. ∙ 02/01/2022 ∙ NCATS
Nancy Schoenberg: Listening to Communities to Create Equitable Solutions
University of Kentucky Center for Clinical and Translational Science ∙ 02/01/2022 ∙ CTSA Program

January 2022

What You Need to Know about the MTHFR Gene Mutation
Ketogenic.com ∙ 01/31/2022 ∙ GARD
Study Examines Pandemic Impact on Suicide Attempt Survivors
University of Kentucky Center for Clinical and Translational Science ∙ 01/27/2022 ∙ CTSA Program
Why Scientists Are Racing to Develop More COVID Antivirals
Cornell University, College of Veterinary Medicine ∙ 01/27/2022 ∙ Division of Preclinical Innovation
Uncontrolled Blood Pressure Is Sending More People to the Hospital
Cedars-Sinai ∙ 01/27/2022 ∙ CTSA Program
NIH Seeks Input on Rural Telehealth Research Needs
American Academy of Family Physicians ∙ 01/27/2022 ∙ NCATS
BU Researchers Identify a New Protein That Enables SARS-CoV-2 Access into Cells
Boston University School of Medicine ∙ 01/26/2022 ∙ CTSA Program
Culturally-Centered Care Increases Feelings of Respect, Autonomy for Birthing People of Color
University of Minnesota ∙ 01/25/2022 ∙ CTSA Program
NCI Support for Basic Science Paves Way for Kidney Cancer Drug Belzutifan
NIH Director's Blog ∙ 01/25/2022 ∙ GARD
SpaceX CRS-24 Splashes Down Safely after One Month on the ISS, Returns Science to Researchers on Earth
ISS National Laboratory ∙ 01/25/2022 ∙ Tissue Chip
New Study Validates Benefits of Convalescent Plasma for Some Patients with COVID-19
NYU Langone Health ∙ 01/25/2022 ∙ CTSA Program
Men Prone to Anxiety, Worry May Develop More Risk Factors for Heart Disease, Stroke and Diabetes
American Heart Association, Inc. ∙ 01/24/2022 ∙ CTSA Program
Why Scientists Are Racing to Develop More COVID Antivirals
Head Topics ∙ 01/24/2022 ∙ Division of Preclinical Innovation
Essentia Health Joins Nationwide Study to Test Medications for COVID-19
Essentia Health ∙ 01/24/2022 ∙ CTSA Program
123rd ACD Session Focuses on Maintaining Momentum
NIH Record ∙ 01/21/2022 ∙ Bespoke Gene Therapy Consortium
Scientists Find Predictors of Heart Disease among Black Americans That Are Shared across Ethnicities
Beth Israel Deaconess Medical Center ∙ 01/21/2022 ∙ CTSA Program
Should Alcohol Have Warning Labels about Cancer Risk? Most Americans Say ‘Yes’
University of Virginia ∙ 01/20/2022 ∙ CTSA Program
NIH Awards $170 Million for Precision Nutrition Study
NIH Common Fund ∙ 01/20/2022 ∙ All of Us Research Program
NIH Funds CUNY SPH and West Point AI Center for Precision Nutrition and Health
CUNY Graduate School of Public Health & Health Policy ∙ 01/20/2022 ∙ All of Us Research Program
Early Stage Investigator Spotlight: Danielle Arnold Explores Transplant Strategies for Primary Immune Deficiencies
Rare Diseases Clinical Research Network ∙ 01/19/2022 ∙ RDCRN
Race-Based Prescribing for Black People with High Blood Pressure Shows No Benefit
University of California, San Francisco ∙ 01/18/2022 ∙ CTSA Program
Self-Compassion May Support a Healthy Heart
NHLBI ∙ 01/18/2022 ∙ CTSA Program
Survival Rate Increases for Extremely Preterm Infants in NIH-Funded Research Network
NICHD ∙ 01/18/2022 ∙ NCATS
Weight Loss before Fertility Treatment May Not Increase Births for Obese Women
Penn State ∙ 01/18/2022 ∙ CTSA Program
College of Health Faculty Awarded Federal, State Grants to Address Health Concerns
Lehigh University ∙ 01/18/2022 ∙ NCATS
New Paper Proposes Diversity, Equity and Inclusion Measures to Combat Structural Health Inequities
UC Davis Health ∙ 01/15/2022 ∙ CTSA Program
Pilot RCT of Angiotensin II vs. Vasopressin in Septic Shock
ClinicalTrials.gov ∙ 01/14/2022 ∙ NCATS
E-Cigarette Users Who Test Positive for COVID-19 Are More Likely to Experience COVID-19 Symptoms
Mayo Clinic ∙ 01/13/2022 ∙ CTSA Program
UCLA-Led Team Refines 'Kick and Kill' Strategy Aimed at Eliminating HIV-Infected Cells
University of California, Los Angeles ∙ 01/11/2022 ∙ CTSA Program
Clear Creek Bio Advances Its Highly Potent SARS-CoV-2 PLpro Inhibitors in Discovery of an Oral Direct-Acting Antiviral to Treat COVID-19
Clear Creek Bio, Inc. ∙ 01/06/2022 ∙ NCATS
Winners of Biomedical Innovation Program Awards Address Significant Clinical Problems
Oregon Health & Science University ∙ 01/04/2022 ∙ CTSA Program
Alumnus and Engineer Collaborate on 3D Printing to Advance Microfluidic Systems
Virginia Polytechnic Institute and State University ∙ 01/03/2022 ∙ SBIR/STIR
Making Hard Choices: A Bioethicist on Crisis Standards of Care
DailyNurse.com ∙ 01/03/2022 ∙ NCATS

December 2021

Ovarian Cancer Researchers Bring Natural Product β-escin to the Fore
University of Chicago Medicine ∙ 12/27/2021 ∙ Division of Preclinical Innovation
What Makes an mRNA Vaccine so Effective Against Severe COVID-19?
Washington University School of Medicine in St. Louis ∙ 12/23/2021 ∙ CTSA Program
Early Use of Convalescent Plasma May Help Outpatients with COVID-19 Avoid Hospitalization
Johns Hopkins Medicine ∙ 12/21/2021 ∙ CTSA Program
Emulate Brain-Chip to Study the Effects of Microgravity on Human Brain Physiology at the International Space Station
Emulate ∙ 12/21/2021 ∙ Tissue Chip
Health Disparities Emerge in Blood Pressure Control
NHLBI ∙ 12/21/2021 ∙ CTSA Program
A Living Pain Circuit
Tulane University, AxoSim, Inc. ∙ 12/21/2021 ∙ HEAL
What Is Engaged Scholarship and How Can It Improve Your Research?
Inside Higher Ed ∙ 12/20/2021 ∙ CTSA Program
Gene Therapy Consortium Provides New Hope for Rare Disease Suffers
North Carolina Biotechnology Center ∙ 12/16/2021 ∙ Bespoke Gene Therapy Consortium
Patient Spotlight: Mitchell Magyar Makes an Impact on Urea Cycle Disorder Research
Rare Diseases Clinical Research Network ∙ 12/16/2021 ∙ RDCRN
UF Leads Team Ready to Tackle Vaccine Skepticism in Florida and Beyond
University of Florida Health ∙ 12/16/2021 ∙ CTSA Program
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
University of California, San Francisco ∙ 12/15/2021 ∙ CTSA Program
Digital Therapy for Prenatal Insomnia May Prevent Postpartum Depression
University of California, San Francisco, Weill Institute for Neurosciences ∙ 12/15/2021 ∙ CTSA Program
SpaceX CRS-24 Launching Multiple Life Science Investigations to the International Space Station
ISS National Laboratory ∙ 12/15/2021 ∙ Tissue Chip
Daytime Meals May Reduce Health Risks of Night Shift Work
NIH Research Matters ∙ 12/14/2021 ∙ CTSA Program
Editorial: Sporadic Early-Onset Colorectal Cancer—Appreciating Aetiologic Complexity
Alimentary Pharmacology & Therapeutics ∙ 12/14/2021 ∙ CTSA Program
SpaceX CRS-24 Mission Overview
ISS National Laboratory ∙ 12/13/2021 ∙ Tissue Chip
Australian GenesisCare Doctors Co-Author World-First International Consensus Statement on Cardio-Oncology
GenesisCare ∙ 12/13/2021 ∙ CTSA Program
Early Investigator Spotlight: UCDC Trainees Drive Discoveries in Urea Cycle Disorders
Rare Diseases Clinical Research Network ∙ 12/09/2021 ∙ RDCRN
E-Cigs with Cigarette-like Nicotine Delivery May Help Smokers Quit
Penn State ∙ 12/08/2021 ∙ CTSA Program
Youth with Autism Spectrum Disorder Should be Screened for Abnormal Cholesterol Levels, Physicians Recommend
Kennedy Krieger Institute ∙ 12/07/2021 ∙ CTSA Program
Antipsychotic Drugs May Increase Risk of Breast Cancer
Washington University School of Medicine in St. Louis ∙ 12/06/2021 ∙ CTSA Program
Consortium Spotlight: Advancing Discoveries in Urea Cycle Disorders
Rare Diseases Clinical Research Network ∙ 12/03/2021 ∙ RDCRN
Rescuing Drug Castoffs
HSP Research Foundation ∙ 12/01/2021 ∙ New Therapeutic Uses
Platforms of Hope: Realizing the Potential of Genetic Medicines
Global Genes ∙ 12/01/2021 ∙ Bespoke Gene Therapy Consortium, Rare Diseases
Who Develops Mild Cognitive Impairment? What Predicts Who Then Develops Dementia?
American Academy of Neurology ∙ 12/01/2021 ∙ CTSA Program

November 2021

Encouraging News on Gene Therapy for Hemophilia A
NIH Director's Blog ∙ 11/30/2021 ∙ GARD
Franciscan Health Michigan City Joins Nationwide Study to Test COVID-19 Medication Efficacy
Franciscan Health Michigan City ∙ 11/30/2021 ∙ CTSA Program
Smartwatch Data Used to Predict Clinical Test Results
NIBIB ∙ 11/30/2021 ∙ CTSA Program
Research Supports Multidisciplinary Approach for Pediatric Diabetes Management
University of Kentucky ∙ 11/30/2021 ∙ CTSA Program
Recognizing This Season of Giving
Kansas Common Sense ∙ 11/29/2021 ∙ CTSA Program
COVID-19: Ciclesonide Failed to Accelerate Recovery in Mild Disease
Physician's Weekly ∙ 11/26/2021 ∙ CTSA Program
Pinpointing Cancer Therapy Targets
Cedars Sinai ∙ 11/24/2021 ∙ CTSA Program
Santhera and ReveraGen Announce Positive Topline Results with Vamorolone after Completion of the VISION-DMD Study
Santhera Pharmaceuticals and ReveraGen BioPharma, Inc. ∙ 11/23/2021 ∙ NCATS
Boosters Increase Protection over Full Vaccine Dose
Northwestern University ∙ 11/22/2021 ∙ CTSA Program
Senators Moran and Blunt Welcome NIH’s Dr. Rutter to KU Medical Center to Visit the Clinical and Translational Science Institute, Frontiers
University of Kansas Medical Center ∙ 11/22/2021 ∙ CTSA Program
Hesperos Validates Utility of Human-on-a-Chip® Approach to Model Rare Autoimmune Disease, Myasthenia Gravis
Hesperos, Inc. ∙ 11/22/2021 ∙ Tissue Chip
Researchers Use Model of Hypothalamus to Implicate Genes Associated with Sleep, BMI, Puberty, and More
Children’s Hospital of Philadelphia ∙ 11/19/2021 ∙ CTSA Program
iTHRIV Funds Efforts to Combat Obesity, Understand Self-Harm, and Reduce Waste by Virginia Tech Scientists and Partners
Virginia Polytechnic Institute and State University ∙ 11/19/2021 ∙ CTSA Program
Winners Announced for 2021 Innovation Challenge
Loyola University Chicago, Parkinson School of Health Sciences and Public Health ∙ 11/18/2021 ∙ SBIR/STIR
New Analyses of Two AZD7442 COVID-19 Phase III Trials in High-Risk Populations Confirm Robust Efficacy and Long-Term Prevention
AstraZeneca ∙ 11/18/2021 ∙ CTSA Program
Fatal Heart Attack or Stroke Could Be First Sign of CVD in Some Smokers
American Heart Association, Inc. ∙ 11/17/2021 ∙ CTSA Program
Smokers More Likely to Die from Heart Disease than Lung Cancer
ClinicalNews.org - AlchePharma ∙ 11/17/2021 ∙ CTSA Program
iTHRIV Backs Bids to Improve Lung Transplant Outcomes, Reduce Waste
University of Virginia ∙ 11/16/2021 ∙ CTSA Program
The Search for the ‘Unknown Known’
The University of Alabama at Birmingham ∙ 11/16/2021 ∙ Biomedical Data Translator
Patient Spotlight: Fynan Family Fueled by OI Research
Rare Diseases Clinical Research Network ∙ 11/16/2021 ∙ RDCRN
How to Solve the Tragedy of the Commons Caused by Reliance on the Patent System to Develop New Drugs
Crowd Funded Cures ∙ 11/16/2021 ∙ NCATS
NIH Applicant Assistance Program (AAP) Now Open – 11/15/21
Innovation Partnership ∙ 11/15/2021 ∙ SBIR/STIR
VUMC Tests Drugs for COVID Outpatient Treatment
Vanderbilt University Medical Center ∙ 11/11/2021 ∙ CTSA Program
Compound Developed at UArizona Health Sciences Provides Innovative Pain Relief
The University of Arizona Health Sciences ∙ 11/10/2021 ∙ Division of Preclinical Innovation
Virpax Advances Envelta™ Development with NCATS Under CRADA Agreement
Virpax® Pharmaceuticals, Inc. ∙ 11/10/2021 ∙ NCATS
Retrospective Study Finds That Cancer Drug Also Lowers Blood Glucose
Mayo Clinic ∙ 11/09/2021 ∙ CTSA Program
University Launches Effort to ‘Revolutionize the Undergraduate Experience’
University of Miami ∙ 11/09/2021 ∙ SBIR/STIR
Mindfulness Linked to Better Psychological Health a Year or Longer after Cardiac Arrest
American Heart Association, Inc. ∙ 11/08/2021 ∙ NCATS
Programing the Body to Make Its Own Medicine with Gene Therapy
Global Genes ∙ 11/05/2021 ∙ Bespoke Gene Therapy Consortium
School-Based Screening Increases Identification of, Treatment for Depression
Penn State College of Medicine ∙ 11/05/2021 ∙ CTSA Program
UT Southwestern designated founding Rare Disease Center of Excellence
The University of Texas Southwestern Medical Center ∙ 11/04/2021 ∙ Rare Diseases
Memories… Or Why Inflammatory Arthritis Always Recurs in Certain Joints
Mirage News ∙ 11/04/2021 ∙ CTSA Program
2022 K Scholar Program to Launch with RFP Release on November 15
University at Buffalo, Clinical and Translational Science Institute ∙ 11/03/2021 ∙ CTSA Program
Opportunities and Disruption in Healthcare Spark CVP’s Acquisition of Atlas
Corporate Growth…Capital Style ∙ 11/03/2021 ∙ NCATS
MPower Grant Supports University of Maryland, College Park and Baltimore Clinical and Translational Research Collaborations
MPower Maryland ∙ 11/03/2021 ∙ CTSA Program
$1.7M MPower Grant to Support UMCP, UMB Health Research Collaborations
University of Maryland ∙ 11/03/2021 ∙ CTSA Program
Partnership to Expand Effective Gene Therapies for Rare Diseases
NIH Director's Blog ∙ 11/02/2021 ∙ Bespoke Gene Therapy Consortium
Retraining the Brain to Treat Chronic Pain
NIH Research Matters ∙ 11/02/2021 ∙ CTSA Program
Unexpected Antibody Type Found in People with Malaria Infections
University of Maryland School of Medicine ∙ 11/02/2021 ∙ CTSA Program
Sanford and NIH Raise Awareness on the Cost of Rare Diseases
Sanford Health ∙ 11/02/2021 ∙ NCATS
With Awards Totaling $446M, UIC Sets Record for Annual Research Funding
University of Illinois at Chicago ∙ 11/01/2021 ∙ CTSA Program

October 2021

Machine Learning May Be the Right Tool for Predicting Success of Opioid Dispensing Outcomes
Columbia University, Mailman School of Public Health ∙ 10/28/2021 ∙ CTSA Program
ICTS Core Provides Foundation for Unprecedented Pediatric COVID Collaboration
Washington University in St. Louis, Institute of Clinical and Translational Sciences ∙ 10/28/2021 ∙ CTSA Program
Narratives of Discovery – Article 4: Wendy Chung
Columbia University, Irving Institute for Clinical and Translational Research ∙ 10/27/2021 ∙ CTSA Program
NIH and FDA Announce Postdoctoral Fellowship Opportunity
University of North Carolina School of Medicine ∙ 10/27/2021 ∙ NCATS
FDA, NIH, and 15 Private Organizations Join Forces to Increase Effective Gene Therapies for Rare Diseases
U.S. Food and Drug Administration ∙ 10/27/2021 ∙ Bespoke Gene Therapy Consortium
Mapping the Mammalian Motor Cortex
NIH Research Matters ∙ 10/26/2021 ∙ CTSA Program
Common Drug May Have Potential for Treating Alzheimer’s Disease
NIH Research Matters ∙ 10/26/2021 ∙ New Therapeutic Uses
Mereo Receives U.S. Orphan Drug Designation for Alvelestat in Treatment of AATD
Mereo BioPharma Group plc ∙ 10/26/2021 ∙ NCATS
The Path from Pollutants in Food to a Heightened Allergic Response
The Ohio State University ∙ 10/26/2021 ∙ CTSA Program
MU Joins Nationwide Clinical Study to Test Medications for Mild-to-Moderate COVID-19
University of Missouri ∙ 10/26/2021 ∙ CTSA Program
'Chipping’ Away at Personalized Medicine
National Aeronautics and Space Administration ∙ 10/25/2021 ∙ Tissue Chip
NIAID-NCATS Collaboration Identifies Potential Viral Treatment
NIAID ∙ 10/22/2021 ∙ Division of Preclinical Innovation
Medical Cost for Rare Diseases on Par with Cancer, Heart Failure
Global Genes ∙ 10/22/2021 ∙ Rare Diseases
Penn State Receives $25 Million to Enhance Medical Research, Human Health
Penn State ∙ 10/21/2021 ∙ CTSA Program
Ethical and Policy Guidance for Translational Xenotransplantation Clinical Trials
The Hastings Center ∙ 10/20/2021 ∙ NCATS
Findings of a VCU Study Reveal the True Burden of the Hidden Pandemic of Fatty Liver Disease
Virginia Commonwealth University ∙ 10/20/2021 ∙ CTSA Program
Recro Awarded Development and Manufacturing Contract by National Institutes of Health (NIH) to Support Novel Nasal Spray Analgesic
Recro Pharma, Inc. ∙ 10/20/2021 ∙ NCATS
Dr. Tara Mehta & Urban Initiatives: A Partnership to Promote Children’s Mental Health
The University of Illinois at Chicago Center for Clinical and Translational Science ∙ 10/18/2021 ∙ CTSA Program
NCATS ASPIRE Challenge Update: AnaBios, Georgia Tech University Team Advance to Next Round in Effort to Discover Non-addictive Pain Drug Candidates
AnaBios ∙ 10/15/2021 ∙ ASPIRE
SSI Researchers Contribute to Ongoing Success of the SC Clinical and Translational Science Institute
University of Southern California, Dornsife Spatial Sciences Institute ∙ 10/15/2021 ∙ CTSA Program
FSU College of Medicine Researcher Will Study Spread of HIV with $6.5 Million NIH Grant
Florida State University ∙ 10/13/2021 ∙ CTSA Program
Never Heard of It
SlowItDownCKD ∙ 10/11/2021 ∙ GARD
AZD7442 Reduced Risk of Developing Severe COVID-19 or Death in TACKLE Phase III Outpatient Treatment Trial
AstraZeneca ∙ 10/11/2021 ∙ Division of Preclinical Innovation
Data Finds Universal Masking Limits School Transmission of COVID-19 Despite Delta Variant
Duke University Health System ∙ 10/08/2021 ∙ CTSA Program
VCU Continues Streak with New All-Time High of $363M in Sponsored Research
Virginia Commonwealth University ∙ 10/08/2021 ∙ CTSA Program
iTHRIV Scholar Career Development Program Applications Open
Virginia Polytechnic Institute and State University ∙ 10/06/2021 ∙ CTSA Program
Early-Stage Drug Candidate Diminishes Deficits in Parkinson’s Disease
University of Utah Health ∙ 10/06/2021 ∙ Division of Preclinical Innovation
UCI-Led Study Finds Psychological Therapy Reduces Biobehavioral Impact of Testicular Cancer
University of California, Irvine ∙ 10/06/2021 ∙ CTSA Program
AZD7442 Request for Emergency Use Authorization for COVID-19 Prophylaxis Filed in US
AstraZeneca ∙ 10/05/2021 ∙ Division of Preclinical Innovation
Virtual CTSI Pilot Studies Colloquium set for October 15
University at Buffalo, Clinical and Translational Science Institute ∙ 10/05/2021 ∙ CTSA Program
UR CTSI Helps Make Connection That Spurs $10M Grant to Study Concussion
University of Rochester Clinical & Translational Science Institute ∙ 10/05/2021 ∙ CTSA Program
Accepting Applications for NCATS/FDA Fellowship
University of Maryland, Robert E. Fischell Institute for Biomedical Devices ∙ 10/05/2021 ∙ NCATS
At-Risk Teens May Face Increased Online Threats
Penn State ∙ 10/04/2021 ∙ NCATS
Top Score for USC and Children’s Hospital of Los Angeles’ Joint Clinical and Translational Research Program
University of Southern California, Keck School of Medicine ∙ 10/01/2021 ∙ CTSA Program

September 2021

Hiding in Plain Sight: Established HIV Medication May Also Help Restore Effects of Dystonia
Duke University School of Medicine, Department of Neurology ∙ 09/29/2021 ∙ CTSA Program, Division of Preclinical Innovation
The Role of IT Infrastructure in Pandemic Health Care
Upsite Technologies ∙ 09/29/2021 ∙ CTSA Program
Finding ‘Needle in Haystack’ Becoming Routine at Kebotix
Kebotix ∙ 09/28/2021 ∙ Division of Preclinical Innovation
Study: Peer Messages Improve Chances of Clinical Trial Participation
University of Nebraska–Lincoln ∙ 09/28/2021 ∙ CTSA Program
Yale Center for Clinical Investigation Receives $63.7 Million Grant
Yale Daily News ∙ 09/27/2021 ∙ CTSA Program
Drugs Used by Some Type 2 Diabetics May Lessen Risk for Severe COVID-19 Outcomes
Penn State ∙ 09/27/2021 ∙ CTSA Program
ReveraGen and Santhera Announce FDA Orphan Grant Funding for Clinical Trial with Vamorolone in Becker Muscular Dystrophy
ReveraGen and Santhera ∙ 09/27/2021 ∙ NCATS
Long-Term CRYSVITA® ▼ (burosumab) Treatment Reduces the Burden of Disease in Adults with X-Linked Hypophosphataemia (XLH), a Rare Genetic Metabolic Bone Disease
Kyowa Kirin Co., Ltd. ∙ 09/24/2021 ∙ Rare Diseases
Creating a Playbook for Bespoke Gene Therapies
Global Genes ∙ 09/24/2021 ∙ Rare Diseases
Deep Learning Helps Predict New Drug Combinations to Fight COVID-19: Neural Network Identifies Synergistic Drug Blends for Treating Viruses Like SARS-CoV-2
Massachusetts Institute of Technology ∙ 09/24/2021 ∙ Division of Preclinical Innovation
Harvard’s Wyss Institute Receives Funding Award from BARDA
Wyss Institute ∙ 09/24/2021 ∙ Tissue Chip
Rare Leader: Shari Hume, Co-Founder, Cure JM Foundation
Global Genes ∙ 09/23/2021 ∙ NCATS
Sequencing Every Newborn’s Genome to Detect Diseases Faces Ethical and Practical Obstacles, but the United Kingdom Is Pushing Ahead with a Major Test
American Association for the Advancement of Science ∙ 09/23/2021 ∙ Rare Diseases
New Kidney Function Test Takes Race Out of the Equation
University of California, San Francisco ∙ 09/23/2021 ∙ NCATS
Adjusting Fatty Acid Intake May Help with Mood Variability in Bipolar Disorders
Penn State ∙ 09/23/2021 ∙ CTSA Program
Engineering a Better Way to Deliver Therapeutic Genes to Muscles
NIH Director's Blog ∙ 09/21/2021 ∙ GARD
Early-Stage Drug Candidate Diminishes Deficits in Parkinson's Disease
University of Utah Health ∙ 09/20/2021 ∙ Division of Preclinical Innovation
Predicting Influenza Virus Evolution in a Human Lung Airway Chip
Wyss Institute ∙ 09/20/2021 ∙ Tissue Chip
Virpax to Develop Intranasal Cannabidiol Product for the Management of Epilepsy in Adults and Children
Virpax® Pharmaceuticals, Inc. ∙ 09/20/2021 ∙ NCATS
Study Investigates Potential Links between IVF and Cardiovascular Risk
UCHealth ∙ 09/17/2021 ∙ CTSA Program
Deep Learning Helps Predict New Drug Combinations to Fight COVID-19
Massachusetts Institute of Technology, Computer Science & Artificial Intelligence Laboratory ∙ 09/16/2021 ∙ Division of Preclinical Innovation
How Palantir Foundry Helps Customers Build and Deploy AI-Powered Decision-Making Applications
Palantir Technologies ∙ 09/15/2021 ∙ CTSA Program
Major Federal Translational Science Support Is Renewed for Yale School of Medicine
Yale School of Medicine ∙ 09/15/2021 ∙ CTSA Program
Patients with Opioid Use Disorder Die at a Rate Similar to Heart Attacks
Oregon Health & Science University ∙ 09/13/2021 ∙ CTSA Program
Hiring Away
Science ∙ 09/13/2021 ∙ Division of Preclinical Innovation
CLIC Cohorts for Change Workshop Series Kickoff & Webpage Launch
Center for Leading Innovation and Collaboration (CLIC) ∙ 09/10/2021 ∙ CTSA Program
Study: No Serious COVID-19 Vaccine Side Effects in Breastfeeding Moms, Infants
UC San Diego Health ∙ 09/08/2021 ∙ CTSA Program
HIV Drug Shows Potential to Combat Genetic Form of Dystonia in Preclinical Study
University of Florida Health ∙ 09/08/2021 ∙ CTSA Program, Division of Preclinical Innovation
Narratives of Discovery – Article 3: Nabila El-Bassel
Columbia University, Irving Institute for Clinical and Translational Research ∙ 09/08/2021 ∙ CTSA Program
Researcher Engagement, Scientific Productivity Linked in Infrastructure Grants
Brown School at Washington University in St. Louis ∙ 09/07/2021 ∙ CTSA Program
How CTSA Program Hubs Across The U.S. Are Vaccinating Their Communities Against COVID-19
University of Rochester Center for Leading Innovation and Collaboration ∙ 09/01/2021 ∙ CTSA Program
COVID-19 Transmission at School Rare for Children with Disabilities
Washington University in St. Louis ∙ 09/01/2021 ∙ CTSA Program
COVID-19 Transmission at School Rare for Children with Disabilities
Washington University in St. Louis ∙ 09/01/2021 ∙ CTSA Program

August 2021

Managing the ISS National Lab: A CASIS Retrospective
ISS National Laboratory ∙ 08/31/2021 ∙ Tissue Chip
Liquid Biopsies May Aid Diagnosis, Treatment of Bladder, Nerve Tumors
Washington University in St. Louis ∙ 08/31/2021 ∙ CTSA Program
COVID-19 Vaccine Elicits Antibodies in 90% Taking Immunosuppressants
Washington University in St. Louis ∙ 08/30/2021 ∙ CTSA Program
Home Health Care Services Reduce Re-Hospitalizations for Medicare Patients with Diabetes
Rutgers, The State University of New Jersey ∙ 08/30/2021 ∙ CTSA Program
Protein Receptor in Endothelial Cells Promotes Lung Healing
University of Illinois ∙ 08/30/2021 ∙ CTSA Program
Researchers Take Step to Using Cellular Movement to Help Wound Healing
Princeton University, School of Engineering and Applied Science ∙ 08/30/2021 ∙ NCATS
Watch Live: UK Receives $23.5 Million Clinical and Translational Science Award from the NIH
University of Kentucky ∙ 08/30/2021 ∙ CTSA Program
Collaborative Seroprevalence Study Highlights Protein Expression Laboratory’s Capabilities
Frederick National Laboratory for Cancer Research ∙ 08/25/2021 ∙ NCATS
The Amazing Brain: Tracking Molecular Events with Calling Cards
NIH Director's Blog ∙ 08/24/2021 ∙ CTSA Program
Genomic Sequencing of Healthy Newborns Does Not Disrupt Family Dynamics
Baylor College of Medicine ∙ 08/23/2021 ∙ CTSA Program
Sadtler Pauses Tissue Engineering Project to Launch Antibody Protocol
NIH Record ∙ 08/20/2021 ∙ Division of Preclinical Innovation
UAMS Researcher Leading $3.1 Million Preschool Intervention to Reduce Obesity and Cancer in Arkansas, Louisiana
University of Arkansas for Medical Sciences ∙ 08/19/2021 ∙ CTSA Program
Antibodies Elicited by COVID-19 Vaccination Effective against Delta Variant
Washington University School of Medicine in St. Louis ∙ 08/17/2021 ∙ CTSA Program
Heat-Controllable CAR T-Cells Destroy Tumors and Prevent Relapse in New Study
Georgia Tech ∙ 08/17/2021 ∙ CTSA Program
Study: Pregnant Women Do Well with COVID Vaccine
University of Washington ∙ 08/17/2021 ∙ CTSA Program
UK Selected as Site for COVID-19 Vaccine Booster Study
University of Kentucky ∙ 08/11/2021 ∙ CTSA Program
Russian Doping of a Different Sort: Russian and Eastern European Drugs Hiding in Plain Sight as Alternative Doping Agents
The Catlin Perspective ∙ 08/11/2021 ∙ NCATS
New Utah Clinical and Translational Science Institute Helps Research Improve Human Health
The University of Utah ∙ 08/10/2021 ∙ CTSA Program
NIBIB-Funded Bioengineers Hit Neurons with Targeted Ultrasound in Approach to Inhibit Pain
NIBIB ∙ 08/10/2021 ∙ NCATS
UAMS Research Sheds Light on Vaccine Hesitancy in Arkansas
University of Arkansas for Medical Sciences ∙ 08/10/2021 ∙ CTSA Program
Nationwide Clinical Study Expands Platform to Test Medications to Treat Mild-to-Moderate COVID-19
Duke Clinical Research Institute ∙ 08/10/2021 ∙ CTSA Program
Cats Prefer to Get Free Meals Rather Than Work for Them
University of California, Davis ∙ 08/09/2021 ∙ CTSA Program
NIDA Office of Acquisitions Contracting
NIDA ∙ 08/06/2021 ∙ NCATS
NCCIH Administrative Supplements for Scholars Pursuing Complementary Health Research Career Development
NCCIH ∙ 08/05/2021 ∙ CTSA Program
Why Food Companies Sponsor Research: the Beef Checkoff Explains
Food Politics ∙ 08/04/2021 ∙ CTSA Program
Nanotech Device Detects Risk for Serious Pregnancy Complication
Cedars-Sinai ∙ 08/03/2021 ∙ CTSA Program
Utah Clinical and Translational Science Institute Advances Efforts to Translate Discoveries to Impact Human Health
University of Utah Health ∙ 08/03/2021 ∙ CTSA Program
Igniting Hope: ‘Healing Historical Trauma from Racist Research, Policies and Practices’
University at Buffalo ∙ 08/03/2021 ∙ CTSA Program

July 2021

Science Update: Fibroid Risk Associated with Ancestry among Black and White Women, NIH-Funded Study Suggests
NICHD ∙ 07/29/2021 ∙ NCATS
Drug for CMV Infections among Pregnant Woman Proves Ineffective
Duke University Health System ∙ 07/28/2021 ∙ CTSA Program
NRL Scientists, Researchers Win 2021 Dr. Delores Etter Award
U.S. Naval Research Laboratory ∙ 07/28/2021 ∙ Division of Preclinical Innovation
Saving Lives in Black Barbershops
Cedars-Sinai ∙ 07/26/2021 ∙ CTSA Program
Research Suggests Ending Eviction Moratoriums Led to Spikes in COVID Cases and Deaths
University of California, Los Angeles ∙ 07/26/2021 ∙ CTSA Program